Osteoporosis After 50: What a DEXA Scan Shows and the New Bone Drugs

A broken wrist from a minor fall, a spine that seems to shrink year by year — these are often the first signs of osteoporosis, a condition that quietly weakens bone until something snaps. After 50, screening and a new generation of bone-building drugs can prevent that first fracture. This guide explains what a DEXA scan tells you and how the newest treatments work.

Key Takeaways

• A DEXA scan produces a T-score; osteoporosis is defined as a T-score at or below −2.5 (Endocrine Society).
• The USPSTF recommends bone-density screening for women 65 and older, and younger women at higher risk (USPSTF, 2025).
• Romosozumab, an anabolic drug, increased lumbar spine bone density by 9.2% and hip density by 3% over 12 months in a 2026 DEXA study of women aged 52–96 (Bone, 2026).
• Anabolic drugs like romosozumab work best first, then are followed by an antiresorptive such as a bisphosphonate to lock in gains.

What Does a DEXA Scan Actually Measure?

DEXA (dual-energy X-ray absorptiometry) is the gold-standard bone-density test. It scans the hip and spine and converts the result into a T-score comparing your bone density to a healthy young adult. A score of −1.0 or above is normal; −1.0 to −2.5 is osteopenia (lower than ideal); at or below −2.5 is osteoporosis (Endocrine Society). From that scan, clinicians calculate a FRAX score estimating your 10-year fracture risk.

The test is quick, low-radiation, and painless. Its value is catching weak bone before a fracture forces the issue.

Evidence capsule: In a 2026 prospective DEXA study of 186 postmenopausal women (median age 76) treated with romosozumab for one year, lumbar spine bone density rose 9.2% and hip density 3%, with gains independent of age — including in women over 80 (Bone, 2026).

Who Should Get Screened After 50?

The US Preventive Services Task Force recommends screening all women 65 and older, and younger women whose fracture risk is elevated (USPSTF, 2025). Men are screened less routinely but should be evaluated when risk factors stack up: low body weight, prior fracture, long-term steroid use, smoking, or a parental hip fracture.

Screening matters because bone loss is silent. Many people do not know they have osteoporosis until a vertebra collapses or a hip breaks. A DEXA scan turns that uncertainty into a number you can act on. For the exercise side of bone protection, see our strength training for healthy aging and our women's longevity midlife guide.

How Do the New Bone-Building Drugs Work?

Older drugs mostly slow bone breakdown (antiresorptives: bisphosphonates, denosumab). The newer anabolic drugs — teriparatide, abaloparatide, and romosozumab — actively build new bone. Romosozumab is a monoclonal antibody that blocks sclerostin, a protein that holds bone formation back; blocking it both builds bone and mildly slows resorption (Endocrine Society).

A 2026 analysis reinforced that anabolics work best when used first in very-high-risk patients, then followed by an antiresorptive to preserve the new bone (Endocrine Society; ReachMD, 2025). Romosozumab is given as a monthly injection for up to 12 months, then typically followed by a bisphosphonate.

What About Calcium, Vitamin D, and Protein?

Medication does the heavy lifting in established osteoporosis, but the foundation still matters. The Endocrine Society recommends calcium and vitamin D as an adjunct to therapy. Our vitamin D evidence review covers who actually needs supplementation, and our protein needs guide explains intake for preserving lean tissue that supports bone and balance.

None of these replace a prescribed bone drug when fracture risk is high. They are the supporting cast, not the lead.

Who Should Be Cautious With These Drugs?

Romosozumab carries a boxed warning: it is not for people at high risk of cardiovascular disease or stroke, such as those with a prior heart attack or stroke (Endocrine Society). Bisphosphonates are generally paused after several years ("drug holiday") in lower-risk patients, while denosumab must not be stopped abruptly without a follow-on drug because bone loss can rebound. These are prescription decisions best made with a clinician who knows your full history.

Frequently Asked Questions

At what age should bone screening start?

The USPSTF recommends DEXA screening for all women 65 and older, and for younger women with elevated fracture risk (USPSTF, 2025). Men should be assessed individually when risk factors are present.

Is romosozumab better than the older bone drugs?

It builds bone faster than antiresorptives and is aimed at very-high-risk patients, such as those with multiple vertebral fractures (Endocrine Society). It is not first-line for everyone and has cardiovascular cautions.

Do I need calcium pills if I'm on a bone drug?

Calcium and vitamin D support therapy but are not a substitute for prescription treatment when risk is high (Endocrine Society). Discuss your actual dietary intake with your clinician.

Can exercise rebuild bone?

Weight-bearing and resistance exercise improve strength and balance and help prevent falls, but they do not replace medication for established osteoporosis. Our strength training guide covers the safe approach.

Conclusion

After 50, a DEXA scan turns silent bone loss into an actionable number, and new anabolic drugs like romosozumab can rebuild density that older drugs only slowed. Screening and the right sequence of therapy prevent the fracture that changes everything. Talk to a clinician about your T-score and risk, and build on it with the healthy aging library.